Nabriva Therapeutics PLC (NASDAQ:NBRV)

2.10
Delayed Data
As of Sep 30
 +0.06 / +2.94%
Today’s Change
2.04
Today|||52-Week Range
35.00
-85.97%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2015

2016

2017

2018
AssetsCash36.4M32.8M86.8M102.0M
 
 
 
 
 
Short Term Investment Cash35.2M-3.7M54.0M15.2M
 
 
 
 
 
Cash & Short Term Investments111.2M83.9M86.9M102.2M
 
 
 
 
 
 
ReceivablesReceivables4.2M5.6M5.4M5.4M
 
 
 
 
 
 
InventoriesInventories0.000.000.000.00--
 
Current AssetsPrepaid Expenses608.3K1.2M1.6M1.2M
 
 
 
 
 
Current Assets116.0M90.6M93.8M108.8M
 
 
 
 
 
 
Total AssetsProperty, Plant and Equipment - Gross88.0K3.3M4.4M4.6M
 
 
 
 
 
Depreciation-39.1K-2.8M-3.0M-3.5M
 
 
 
 
 
Intangible Assets3.3K270.0K172.0K98.0K
 
 
 
 
 
Other Assets3.3K270.0K172.0K98.0K
 
 
 
 
 
Total Assets117.6M93.2M95.8M110.4M
 
 
 
 
 
 
LiabilitiesAccounts Payable--2.6M5.1M3.3M
 
 
 
 
Accrued Expenses3.3M0.00----
 
 
Other Current Liabilities7.5M11.2M3.7M7.1M
 
 
 
 
 
Other Liabilities9.3M15.9M13.3M17.8M
 
 
 
 
 
 
Total LiabilitiesLong Term Debt0.000.00232.0K23.7M
 
 
 
Deferred Taxes-614.8K-1.4M0.00--
 
 
 
Other Liabilities0.00107.0K203.0K264.0K
 
 
 
 
Total Liabilities9.5M16.0M13.7M41.8M
 
 
 
 
 
 
EquityMinority Interest0.000.000.000.00--
Preferred Stock0.000.000.000.00--
Common Equity108.1M77.3M82.1M68.6M
 
 
 
 
 
Total Shareholder Equity108.1M77.3M82.1M68.6M
 
 
 
 
 
 
Share InformationCommon Shares Outstanding2.1M2.7M36.7M67.0M
 
 
 
 
 
 
Addtl. Info.No data currently available for this section.